,approvedSymbol,approvedName,prefName,drugType,drugId,phase,ctIds,id,disease
0,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0021095,parkinsonian disorder
1,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
2,CHRM3,cholinergic receptor muscarinic 3,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0021095,parkinsonian disorder
3,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0021095,parkinsonian disorder
4,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
5,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
6,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0021095,parkinsonian disorder
7,DRD3,dopamine receptor D3,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0021095,parkinsonian disorder
8,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
9,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT00477802'],MONDO_0021095,parkinsonian disorder
10,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
11,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
12,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
13,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0021095,parkinsonian disorder
14,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
15,SCN1A,sodium voltage-gated channel alpha subunit 1,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
16,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0021095,parkinsonian disorder
17,DRD4,dopamine receptor D4,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0021095,parkinsonian disorder
18,SCN10A,sodium voltage-gated channel alpha subunit 10,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
19,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT04952194', 'NCT06013956', 'NCT06236230']",MONDO_0021095,parkinsonian disorder
20,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
21,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
22,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
23,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,VARENICLINE,Small molecule,CHEMBL1076903,4.0,['NCT02473562'],MONDO_0021095,parkinsonian disorder
24,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
25,GABRD,gamma-aminobutyric acid type A receptor subunit delta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
26,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
27,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
28,SCN9A,sodium voltage-gated channel alpha subunit 9,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
29,CHRM1,cholinergic receptor muscarinic 1,TRIHEXYPHENIDYL,Small molecule,CHEMBL1490,4.0,[],MONDO_0021095,parkinsonian disorder
30,DRD4,dopamine receptor D4,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0021095,parkinsonian disorder
31,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,VARENICLINE,Small molecule,CHEMBL1076903,4.0,['NCT02473562'],MONDO_0021095,parkinsonian disorder
32,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
33,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,['NCT05312632'],MONDO_0021095,parkinsonian disorder
34,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
35,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
36,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
37,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0021095,parkinsonian disorder
38,HRH1,histamine receptor H1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
39,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0021095,parkinsonian disorder
40,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0021095,parkinsonian disorder
41,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
42,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0021095,parkinsonian disorder
43,HRH1,histamine receptor H1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
44,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
45,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0021095,parkinsonian disorder
46,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0021095,parkinsonian disorder
47,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
48,DRD2,dopamine receptor D2,DOMPERIDONE,Small molecule,CHEMBL219916,4.0,['NCT03022201'],MONDO_0021095,parkinsonian disorder
49,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
50,DRD5,dopamine receptor D5,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0021095,parkinsonian disorder
51,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02549573', 'NCT02688465']",MONDO_0021095,parkinsonian disorder
52,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
53,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
54,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0021095,parkinsonian disorder
55,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
56,MTNR1A,melatonin receptor 1A,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT03258294', 'NCT02768077']",MONDO_0021095,parkinsonian disorder
57,DRD2,dopamine receptor D2,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0021095,parkinsonian disorder
58,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0021095,parkinsonian disorder
59,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
60,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
61,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,[],MONDO_0021095,parkinsonian disorder
62,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0021095,parkinsonian disorder
63,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
64,MTNR1B,melatonin receptor 1B,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT02768077', 'NCT03258294']",MONDO_0021095,parkinsonian disorder
65,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT01313845', 'NCT01071395', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
66,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,['NCT04373317'],MONDO_0021095,parkinsonian disorder
67,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
68,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
69,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
70,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
71,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
72,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02940912', 'NCT01770145']",MONDO_0021095,parkinsonian disorder
73,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
74,DRD1,dopamine receptor D1,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0021095,parkinsonian disorder
75,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00219284', 'NCT00391898', 'NCT00906828', 'NCT00888186', 'NCT02480803', 'NCT00590122', 'NCT00143026', 'NCT03115827', 'NCT00141518', 'NCT00125567']",MONDO_0021095,parkinsonian disorder
76,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0021095,parkinsonian disorder
77,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
78,CHRM1,cholinergic receptor muscarinic 1,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0021095,parkinsonian disorder
79,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
80,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0021095,parkinsonian disorder
81,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,['NCT00399477'],MONDO_0021095,parkinsonian disorder
82,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT00321854', 'NCT02233023', 'NCT01673724', 'NCT03521635', 'NCT02231905', 'NCT00402233']",MONDO_0021095,parkinsonian disorder
83,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0021095,parkinsonian disorder
84,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
85,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
86,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0021095,parkinsonian disorder
87,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0021095,parkinsonian disorder
88,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0021095,parkinsonian disorder
89,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0021095,parkinsonian disorder
90,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
91,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0021095,parkinsonian disorder
92,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0021095,parkinsonian disorder
93,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0021095,parkinsonian disorder
94,SCN5A,sodium voltage-gated channel alpha subunit 5,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
95,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0021095,parkinsonian disorder
96,DRD3,dopamine receptor D3,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0021095,parkinsonian disorder
97,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0021095,parkinsonian disorder
98,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04821687'],MONDO_0021095,parkinsonian disorder
99,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
100,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,"['NCT00030979', 'NCT01521117']",MONDO_0021095,parkinsonian disorder
101,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
102,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0021095,parkinsonian disorder
103,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0021095,parkinsonian disorder
104,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT00485069', 'NCT01494532', 'NCT01485172', 'NCT00986245']",MONDO_0021095,parkinsonian disorder
105,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
106,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
107,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
108,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0021095,parkinsonian disorder
109,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
110,SCN3A,sodium voltage-gated channel alpha subunit 3,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
111,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00696215', 'NCT01385735', 'NCT01765257', 'NCT01007630']",MONDO_0021095,parkinsonian disorder
112,CHRM1,cholinergic receptor muscarinic 1,ETHOPROPAZINE,Small molecule,CHEMBL1206,4.0,[],MONDO_0021095,parkinsonian disorder
113,MAOB,monoamine oxidase B,RASAGILINE TARTRATE,Small molecule,CHEMBL5315052,4.0,[],MONDO_0021095,parkinsonian disorder
114,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,4.0,['NCT02741947'],MONDO_0021095,parkinsonian disorder
115,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
116,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
117,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT00601978'],MONDO_0021095,parkinsonian disorder
118,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
119,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
120,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,[],MONDO_0021095,parkinsonian disorder
121,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0021095,parkinsonian disorder
122,SCN2A,sodium voltage-gated channel alpha subunit 2,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
123,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
124,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
125,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0021095,parkinsonian disorder
126,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,4.0,[],MONDO_0021095,parkinsonian disorder
127,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
128,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0021095,parkinsonian disorder
129,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT00321854', 'NCT00402233', 'NCT02231905', 'NCT02233023', 'NCT01673724', 'NCT03521635']",MONDO_0021095,parkinsonian disorder
130,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,"['NCT04986995', 'NCT04990284']",MONDO_0021095,parkinsonian disorder
131,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT06115538'],MONDO_0021095,parkinsonian disorder
132,CHRM1,cholinergic receptor muscarinic 1,PROCYCLIDINE,Small molecule,CHEMBL86715,4.0,[],MONDO_0021095,parkinsonian disorder
133,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
134,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,[],MONDO_0021095,parkinsonian disorder
135,CHRM1,cholinergic receptor muscarinic 1,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0021095,parkinsonian disorder
136,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT00141518', 'NCT02480803', 'NCT00590122', 'NCT00143026', 'NCT03115827', 'NCT00888186', 'NCT00219284', 'NCT00906828', 'NCT00125567', 'NCT00391898']",MONDO_0021095,parkinsonian disorder
137,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0021095,parkinsonian disorder
138,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT04990284'],MONDO_0021095,parkinsonian disorder
139,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE MESYLATE,Small molecule,CHEMBL1200383,4.0,[],MONDO_0021095,parkinsonian disorder
140,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0021095,parkinsonian disorder
141,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
142,BCHE,butyrylcholinesterase,RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0021095,parkinsonian disorder
143,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0021095,parkinsonian disorder
144,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
145,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
146,SCN8A,sodium voltage-gated channel alpha subunit 8,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
147,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
148,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
149,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
150,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
151,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0021095,parkinsonian disorder
152,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01071395', 'NCT01313845', 'NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
153,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT00632762', 'NCT01071395', 'NCT04387773', 'NCT01313845']",MONDO_0021095,parkinsonian disorder
154,HTR2C,5-hydroxytryptamine receptor 2C,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0021095,parkinsonian disorder
155,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
156,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0021095,parkinsonian disorder
157,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0021095,parkinsonian disorder
158,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT01485172', 'NCT00485069', 'NCT00986245', 'NCT01494532']",MONDO_0021095,parkinsonian disorder
159,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,['NCT00906828'],MONDO_0021095,parkinsonian disorder
160,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT00632762', 'NCT04387773', 'NCT01071395']",MONDO_0021095,parkinsonian disorder
161,HTR2C,5-hydroxytryptamine receptor 2C,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0021095,parkinsonian disorder
162,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
163,CHRM3,cholinergic receptor muscarinic 3,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0021095,parkinsonian disorder
164,CHRM2,cholinergic receptor muscarinic 2,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0021095,parkinsonian disorder
165,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0021095,parkinsonian disorder
166,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
167,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
168,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
169,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0021095,parkinsonian disorder
170,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0021095,parkinsonian disorder
171,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,[],MONDO_0021095,parkinsonian disorder
172,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
173,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
174,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0021095,parkinsonian disorder
175,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0021095,parkinsonian disorder
176,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0021095,parkinsonian disorder
177,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,4.0,[],MONDO_0021095,parkinsonian disorder
178,DRD2,dopamine receptor D2,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0021095,parkinsonian disorder
179,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,['NCT00601978'],MONDO_0021095,parkinsonian disorder
180,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
181,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
182,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
183,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
184,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0021095,parkinsonian disorder
185,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
186,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
187,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0021095,parkinsonian disorder
188,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
189,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
190,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
191,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,[],MONDO_0021095,parkinsonian disorder
192,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
193,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0021095,parkinsonian disorder
194,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
195,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
196,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0021095,parkinsonian disorder
197,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
198,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,[],MONDO_0021095,parkinsonian disorder
199,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE,Small molecule,CHEMBL1201203,4.0,[],MONDO_0021095,parkinsonian disorder
200,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT01340885', 'NCT03840837', 'NCT00988117']",MONDO_0021095,parkinsonian disorder
201,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,"['NCT00247247', 'NCT00373087', 'NCT02847442', 'NCT00125567', 'NCT00219284', 'NCT00143026', 'NCT00391898', 'NCT00906828']",MONDO_0021095,parkinsonian disorder
202,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT00485069', 'NCT01485172', 'NCT00986245', 'NCT01494532']",MONDO_0021095,parkinsonian disorder
203,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
204,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0021095,parkinsonian disorder
205,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0021095,parkinsonian disorder
206,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0021095,parkinsonian disorder
207,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04986982'],MONDO_0021095,parkinsonian disorder
208,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0021095,parkinsonian disorder
209,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
210,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0021095,parkinsonian disorder
211,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
212,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0021095,parkinsonian disorder
213,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,4.0,['NCT00571285'],MONDO_0021095,parkinsonian disorder
214,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT01048229', 'NCT01178047']",MONDO_0021095,parkinsonian disorder
215,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0021095,parkinsonian disorder
216,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0021095,parkinsonian disorder
217,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01721460', 'NCT02256319', 'NCT01789385']",MONDO_0021095,parkinsonian disorder
218,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0021095,parkinsonian disorder
219,ACHE,acetylcholinesterase (Yt blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT01340885', 'NCT03840837', 'NCT00988117']",MONDO_0021095,parkinsonian disorder
220,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0021095,parkinsonian disorder
221,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00601978'],MONDO_0021095,parkinsonian disorder
222,HTR2A,5-hydroxytryptamine receptor 2A,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0021095,parkinsonian disorder
223,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0021095,parkinsonian disorder
224,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT00888186', 'NCT00485069', 'NCT02769793', 'NCT00141518', 'NCT00399477', 'NCT00914134', 'NCT02741947', 'NCT00906828', 'NCT00125567', 'NCT00590122', 'NCT00219284', 'NCT00153972', 'NCT00391898', 'NCT02847442', 'NCT00272688', 'NCT00143026', 'NCT02480803', 'NCT01770145']",MONDO_0021095,parkinsonian disorder
225,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,4.0,"['NCT00590122', 'NCT03151460', 'NCT02233023']",MONDO_0021095,parkinsonian disorder
226,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
227,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
228,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
229,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
230,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT00632762', 'NCT04387773']",MONDO_0021095,parkinsonian disorder
231,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
232,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0021095,parkinsonian disorder
233,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,"['NCT03843944', 'NCT03841604', 'NCT05312632']",MONDO_0021095,parkinsonian disorder
234,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0021095,parkinsonian disorder
235,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
236,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0021095,parkinsonian disorder
237,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
238,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
239,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0021095,parkinsonian disorder
240,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
241,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
242,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT01770145'],MONDO_0021095,parkinsonian disorder
243,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
244,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01789385', 'NCT01721460', 'NCT02256319']",MONDO_0021095,parkinsonian disorder
245,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0021095,parkinsonian disorder
246,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0021095,parkinsonian disorder
247,SCN11A,sodium voltage-gated channel alpha subunit 11,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
248,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,[],MONDO_0021095,parkinsonian disorder
249,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
250,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00153972'],MONDO_0021095,parkinsonian disorder
251,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
252,ADRB3,adrenoceptor beta 3,MIRABEGRON,Small molecule,CHEMBL2095212,4.0,['NCT02092181'],MONDO_0021095,parkinsonian disorder
253,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0021095,parkinsonian disorder
254,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0021095,parkinsonian disorder
255,DRD2,dopamine receptor D2,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0021095,parkinsonian disorder
256,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,"['NCT00443872', 'NCT00640159', 'NCT04870372']",MONDO_0021095,parkinsonian disorder
257,CHRM1,cholinergic receptor muscarinic 1,BIPERIDEN,Small molecule,CHEMBL1101,4.0,[],MONDO_0021095,parkinsonian disorder
258,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
259,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
260,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01744496', 'NCT00594464', 'NCT01782222', 'NCT01300819', 'NCT03103919', 'NCT01711866', 'NCT01523301']",MONDO_0021095,parkinsonian disorder
261,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0021095,parkinsonian disorder
262,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0021095,parkinsonian disorder
263,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,['NCT00601978'],MONDO_0021095,parkinsonian disorder
264,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
265,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT00632762', 'NCT01071395', 'NCT01313845']",MONDO_0021095,parkinsonian disorder
266,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
267,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0021095,parkinsonian disorder
268,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT06234995', 'NCT06013956', 'NCT04952194', 'NCT06236230']",MONDO_0021095,parkinsonian disorder
269,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
270,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00642356'],MONDO_0021095,parkinsonian disorder
271,ACHE,acetylcholinesterase (Yt blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,['NCT03011476'],MONDO_0021095,parkinsonian disorder
272,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
273,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0021095,parkinsonian disorder
274,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0021095,parkinsonian disorder
275,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
276,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0021095,parkinsonian disorder
277,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
278,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,[],MONDO_0021095,parkinsonian disorder
279,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT01770145', 'NCT02940912']",MONDO_0021095,parkinsonian disorder
280,GABRP,gamma-aminobutyric acid type A receptor subunit pi,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
281,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
282,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
283,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT00594464', 'NCT01711866', 'NCT03103919', 'NCT01782222', 'NCT01300819', 'NCT01523301', 'NCT01744496']",MONDO_0021095,parkinsonian disorder
284,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT02472210'],MONDO_0021095,parkinsonian disorder
285,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT03521635', 'NCT00402233', 'NCT02231905', 'NCT02233023', 'NCT00321854', 'NCT01673724']",MONDO_0021095,parkinsonian disorder
286,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT00632762', 'NCT01071395', 'NCT04387773']",MONDO_0021095,parkinsonian disorder
287,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0021095,parkinsonian disorder
288,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0021095,parkinsonian disorder
289,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
290,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0021095,parkinsonian disorder
291,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
292,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0021095,parkinsonian disorder
293,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0021095,parkinsonian disorder
294,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00174239'],MONDO_0021095,parkinsonian disorder
295,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0021095,parkinsonian disorder
296,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,['NCT02549573'],MONDO_0021095,parkinsonian disorder
297,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
298,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0021095,parkinsonian disorder
299,MTNR1B,melatonin receptor 1B,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0021095,parkinsonian disorder
300,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0021095,parkinsonian disorder
301,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
302,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01789385', 'NCT01721460', 'NCT02256319']",MONDO_0021095,parkinsonian disorder
303,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
304,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT04387773', 'NCT00632762', 'NCT01313845', 'NCT01071395']",MONDO_0021095,parkinsonian disorder
305,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT06236230'],MONDO_0021095,parkinsonian disorder
306,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL5314363,4.0,[],MONDO_0021095,parkinsonian disorder
307,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT01673724', 'NCT02233023']",MONDO_0021095,parkinsonian disorder
308,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0021095,parkinsonian disorder
309,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
310,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0021095,parkinsonian disorder
311,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
312,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02940912', 'NCT01770145']",MONDO_0021095,parkinsonian disorder
313,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
314,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0021095,parkinsonian disorder
315,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,['NCT03968744'],MONDO_0021095,parkinsonian disorder
316,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0021095,parkinsonian disorder
317,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,[],MONDO_0021095,parkinsonian disorder
318,SCN7A,sodium voltage-gated channel alpha subunit 7,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
319,CHRM1,cholinergic receptor muscarinic 1,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0021095,parkinsonian disorder
320,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0021095,parkinsonian disorder
321,SLC6A2,solute carrier family 6 member 2,ATOMOXETINE,Small molecule,CHEMBL641,4.0,['NCT01340885'],MONDO_0021095,parkinsonian disorder
322,MTNR1A,melatonin receptor 1A,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0021095,parkinsonian disorder
323,SCN4A,sodium voltage-gated channel alpha subunit 4,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0021095,parkinsonian disorder
324,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,[],MONDO_0021095,parkinsonian disorder
325,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0021095,parkinsonian disorder
326,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,[],MONDO_0021095,parkinsonian disorder
327,DDC,dopa decarboxylase,CARBIDOPA ANHYDROUS,Small molecule,CHEMBL1201236,4.0,"['NCT04952194', 'NCT06013956', 'NCT06236230']",MONDO_0021095,parkinsonian disorder
328,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00399477', 'NCT00755027', 'NCT01497652', 'NCT01168596', 'NCT00902941', 'NCT01382342', 'NCT01049984', 'NCT01723228']",MONDO_0021095,parkinsonian disorder
329,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0021095,parkinsonian disorder
330,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0021095,parkinsonian disorder
331,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01782222', 'NCT01523301', 'NCT00594464', 'NCT03103919', 'NCT01744496', 'NCT01300819', 'NCT01711866']",MONDO_0021095,parkinsonian disorder
332,CHRM2,cholinergic receptor muscarinic 2,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0021095,parkinsonian disorder
333,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
334,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0021095,parkinsonian disorder
335,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,[],MONDO_0021095,parkinsonian disorder
336,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0021095,parkinsonian disorder
337,CLCN2,chloride voltage-gated channel 2,LUBIPROSTONE,Small molecule,CHEMBL1201134,4.0,['NCT00908076'],MONDO_0021095,parkinsonian disorder
338,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
339,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0021095,parkinsonian disorder
